Breast cancer stage II
(UMLS:C0278486)
- UMLS ID:
- C0278486
- MeSH ID:
- N/A
Synonym(s)
1.
Breast cancer stage II
2.
breast cancer ii stage
3.
breast cancer stage ii
4.
breast cancer, stage II
5.
stage ii breast cancer
Associated Drug(s)
| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Norgestrel | FAERS: 21 | OFFSIDES US FAERS | |
| 2 | Medroxyprogesterone Acetate | FAERS: 7 | OFFSIDES US FAERS | |
| 3 | Estrogens, Conjugated (USP) | FAERS: 4 | US FAERS | |
| 4 | Fingolimod Hydrochloride | FAERS: 4 | US FAERS | |
| 5 | Glatiramer Acetate | FAERS: 4 | US FAERS | |
| 6 | Teriparatide | FAERS: 4 | US FAERS | |
| 7 | Valsartan | FAERS: 4 Canada Vigilance: 2 | Canada Vigilance US FAERS | |
| 8 | etonogestrel | FAERS: 4 | US FAERS | |
| 9 | Raloxifene Hydrochloride | FAERS: 3 | US FAERS | |
| 10 | Clozapine | FAERS: 2 | OFFSIDES US FAERS | |
| 11 | Estradiol | FAERS: 2 | OFFSIDES US FAERS | |
| 12 | Fluoxetine | FAERS: 2 | US FAERS | |
| 13 | Lenalidomide | FAERS: 2 | US FAERS | |
| 14 | Octreotide | FAERS: 2 | US FAERS | |
| 15 | Paliperidone Palmitate | FAERS: 2 | OFFSIDES US FAERS | |
| 16 | 4-hydroxybutyric acid | FAERS: 1 | US FAERS | |
| 17 | Anastrozole | FAERS: 1 | US FAERS | |
| 18 | Bisacodyl | FAERS: 1 | US FAERS | |
| 19 | Desogestrel | FAERS: 1 | US FAERS | |
| 20 | Dimethyl Fumarate | FAERS: 1 | US FAERS | |
| 21 | Duloxetine Hydrochloride | FAERS: 1 | US FAERS | |
| 22 | Finasteride | FAERS: 1 | US FAERS | |
| 23 | Fosamax plus D | FAERS: 1 | US FAERS | |
| 24 | Gabapentin | FAERS: 1 | US FAERS | |
| 25 | Imatinib Mesylate | FAERS: 1 | US FAERS | |
| 26 | Insulin Glargine | FAERS: 1 | US FAERS | |
| 27 | Isotretinoin | FAERS: 1 | US FAERS | |
| 28 | Liraglutide | FAERS: 1 | US FAERS | |
| 29 | Norethindrone | FAERS: 1 | US FAERS | |
| 30 | PCI 32765 | FAERS: 1 | US FAERS | |
| 31 | Ranolazine | FAERS: 1 | US FAERS | |
| 32 | Sitagliptin Phosphate | FAERS: 1 | US FAERS | |
| 33 | Tenofovir | FAERS: 1 | US FAERS | |
| 34 | Zoledronic Acid | FAERS: 1 | US FAERS | |
| 35 | bupropion hydrochloride, naltrexone hydrochoride drug combination | FAERS: 1 | US FAERS | |
| 36 | pirfenidone | FAERS: 1 | US FAERS | |
| 37 | rofecoxib | FAERS: 1 | US FAERS | |
| 38 | Amantadine | OFFSIDES | ||
| 39 | Betaxolol | OFFSIDES | ||
| 40 | Bupropion | OFFSIDES | ||
| 41 | Desvenlafaxine Succinate | OFFSIDES | ||
| 42 | Fluoxetine | OFFSIDES | ||
| 43 | Fosinopril | OFFSIDES | ||
| 44 | Galantamine | OFFSIDES | ||
| 45 | Ketamine | OFFSIDES | ||
| 46 | Ketorolac Tromethamine | OFFSIDES | ||
| 47 | Medroxyprogesterone | OFFSIDES | ||
| 48 | Methylprednisolone Acetate | OFFSIDES | ||
| 49 | Moclobemide | OFFSIDES | ||
| 50 | Orphenadrine | OFFSIDES | ||
| 51 | Progesterone | OFFSIDES | ||
| 52 | Raloxifene Hydrochloride | OFFSIDES | ||
| 53 | Solifenacin Succinate | OFFSIDES | ||
| 54 | Sumatriptan | OFFSIDES | ||
| 55 | Tamoxifen | OFFSIDES | ||
| 56 | norgestimate, ethinyl estradiol drug combination | OFFSIDES | ||
| 57 | pimecrolimus | OFFSIDES |
Powered by :
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120326
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.